Enhanced CB1 receptor function in GABAergic neurons mediates hyperexcitability and impaired sensory-driven synchrony of cortical circuits in Fragile X Syndrome model mice.
Level 5 - mechanism / opinion, no new human data
Preclinical animal model and ex vivo electrophysiological study
PubMed 41272343 · doi:10.1038/s41380-025-03366-6
What was done
Investigators examined the role of endocannabinoid signaling and Cannabinoid Receptor 1 (CB1R) in cortical hyperexcitability using the *Fmr1* knockout (KO) mouse model of Fragile X Syndrome (FXS). They measured persistent network activity (Up states) and inhibitory synaptic currents in ex vivo Layer 2/3 cortical slices, as well as resting and sensory-evoked EEG synchrony in awake mice, evaluating the impact of cell-type-specific genetic manipulations and pharmacological CB1R modulation.
What was found
The abstract reports directional findings without numerical values or effect sizes. Pharmacological or genetic reduction of CB1R specifically in GABAergic neurons reversed prolonged cortical Up states and rescued sensory-driven cortical synchrony deficits in *Fmr1* KO mice. Layer 2/3 pyramidal neurons exhibited enhanced CB1R-mediated suppression of inhibitory synaptic currents. Genetic deletion of *Cnr1* in glutamatergic neurons did not alter Up state duration, but selective deletion of *Fmr1* in glutamatergic neurons was sufficient to generate prolonged Up states.
Why it matters
This study defines a cell-type-specific circuit mechanism linking loss of *Fmr1* in glutamatergic neurons to enhanced CB1R-driven inhibition of GABAergic transmission. It highlights targeted CB1R antagonism as a candidate therapeutic approach to address cortical hyperexcitability and sensory processing deficits in FXS.
Limits
The abstract provides no sample sizes, effect sizes, or statistical confidence measures. Findings are limited to a mouse model and ex vivo preparations, which may not translate directly to human disease, and clinical feasibility or systemic safety of CB1R antagonism was not assessed.
Cited by
- supports Fragile X syndrome model mice exhibit hyperactivity of glutamatergic neuronal networks in their brains.